The 4 analysts offering 1 year price forecasts for 000513 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to 000513 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
000513 EPS for the last quarter is 0.54 CNY despite the estimation of 0.57 CNY. In the next quarter EPS is expected to reach 0.40 CNY. Track more of LIVZON PHARMACEUTI financials and stay on top of what is up with the company.
In the next quarter LIVZON PHARMACEUTI revenue is expected to reach 2.77 B CNY. Check out LIVZON PHARMACEUTI revenue and earnings and make informed decisions.
According to analysts, 000513 price target is 44.82 CNY with a max estimate of 46.50 CNY and a min estimate of 43.96 CNY. Check if this forecast comes true in a year, meanwhile watch LIVZON PHARMACEUTI stock price chart and keep track of the current situation with 000513 news and stock market news.
We've gathered opinions of 9 analysts rating 000513 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.